Immune regulation by CD40 and its ligand GP39

被引:547
|
作者
Foy, TM
Aruffo, A
Bajorath, J
Buhlmann, JE
Noelle, RJ
机构
[1] DARTMOUTH COLL SCH MED,BIOCHEM GRAD PROGRAM,LEBANON,NH 03756
[2] BRISTOL MYERS SQUIBB PHARMACEUT RES INST,SEATTLE,WA 98121
关键词
CD40; CD40L; gp39; structure; peripheral tolerance; central tolerance;
D O I
10.1146/annurev.immunol.14.1.591
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Over the past three years, CD40 and its ligand (gp39, CD40L, TBAM) have been shown to be essential for humoral immune responses to thymus-dependent antigens. However, as the tissue distribution widens for those cells that express CD40 and gp39, we can now show that this ligand-receptor pair also plays an important role in the selection of self-reactive T cells in the thymus (central tolerance) and the regulation of tolerance in mature T cells (peripheral tolerance). Advances in our understanding of the molecular basis for CD40 biology is based in two areas of research. First, a major breakthrough in our understanding of how CD40 transduces biological events centers on the identification of a novel protein that binds to the cytoplasmic tail of CD40 and may act as a signal transducing molecule. Secondly, advances in molecular modeling and mutagenesis of this ligand-receptor pair have helped to identify the critical receptor/ligand contacts in the gp39/CD40 complex. Advances in each of these areas are discussed.
引用
收藏
页码:591 / 617
页数:27
相关论文
共 50 条
  • [21] THE HUMAN T-CELL ANTIGEN GP39, A MEMBER OF THE TNF GENE FAMILY, IS A LIGAND FOR THE CD40 RECEPTOR - EXPRESSION OF A SOLUBLE FORM OF GP39 WITH B-CELL COSTIMULATORY ACTIVITY
    HOLLENBAUGH, D
    GROSMAIRE, LS
    KULLAS, CD
    CHALUPNY, NJ
    BRAESCHANDERSEN, S
    NOELLE, RJ
    STAMENKOVIC, I
    LEDBETTER, JA
    ARUFFO, A
    EMBO JOURNAL, 1992, 11 (12): : 4313 - 4321
  • [22] THE ROLE OF GP39 (CD40L) IN IMMUNITY
    NOELLE, RJ
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1995, 76 (03): : S203 - S207
  • [23] THE ROLE OF CD40L (GP39)/CD40 IN T/B CELL-INTERACTION AND PRIMARY IMMUNODEFICIENCY
    OCHS, HD
    HOLLENBAUGH, D
    ARUFFO, A
    RESEARCH IN IMMUNOLOGY, 1994, 145 (03): : 210 - 215
  • [24] GROWTH OF NORMAL HUMAN B-LYMPHOCYTES IN-VITRO - THE ROLE OF IL-14 AND THE CD40 LIGAND GP39
    AMBRUS, J
    YOSHIMURA, L
    TAMAYO, A
    LEDBETTER, J
    ARUFFO, A
    HOLLENBAUGH, D
    BLUMENTHAL, D
    WEST, R
    FORD, R
    FASEB JOURNAL, 1994, 8 (05): : A1012 - A1012
  • [25] New mutation is identified in GP39 (CD40 ligand) gene in 11 year old boy diagnosed with hypogammaglobulinemia in infancy.
    Bolotin, E
    Seyama, K
    Kempert, P
    Smogorzevska, E
    Kapoor, N
    Weinberg, K
    Ochs, H
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 793 - 793
  • [26] DIMINISHED EXPRESSION OF CD40 LIGAND (GP39) BY ACTIVATED NEONATAL T-CELLS - EFFECT ON IMMUNOGLOBULIN PRODUCTION AND CLASS SWITCHING
    PENIX, LA
    NONOYAMA, S
    EDWARDS, CP
    ARUFFO, A
    WILSON, CB
    OCHS, HD
    PEDIATRIC RESEARCH, 1994, 35 (04) : A73 - A73
  • [27] ROLE OF GP39, THE CD40-LIGAND, IN THE GENERATION AND MAINTENANCE OF B-CELL MEMORY
    LAMAN, JD
    FOY, TM
    NOELLE, RJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 430 - 430
  • [28] ANALYSIS OF GP39/CD40 INTERACTIONS USING MOLECULAR-MODELS AND SITE-DIRECTED MUTAGENESIS
    BAJORATH, J
    MARKEN, JS
    CHALUPNY, NJ
    SPOON, TL
    SIADAK, AW
    GORDON, M
    NOELLE, RJ
    HOLLENBAUGH, D
    ARUFFO, A
    BIOCHEMISTRY, 1995, 34 (31) : 9884 - 9892
  • [29] THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME
    ARUFFO, A
    FARRINGTON, M
    HOLLENBAUGH, D
    LI, X
    MILATOVICH, A
    NONOYAMA, S
    BAJORATH, J
    GROSMAIRE, LS
    STENKAMP, R
    NEUBAUER, M
    ROBERTS, RL
    NOELLE, RJ
    LEDBETTER, JA
    FRANCKE, U
    OCHS, HD
    CELL, 1993, 72 (02) : 291 - 300
  • [30] CD40/CD40 LIGAND INTERACTIONS IN IMMUNE RESPONSES AND PULMONARY IMMUNITY
    Kawabe, Tsutomu
    Matsushima, Miyoko
    Hashimoto, Naozumi
    Imaizumi, Kazuyoshi
    Hasegawa, Yoshinori
    NAGOYA JOURNAL OF MEDICAL SCIENCE, 2011, 73 (3-4): : 69 - 78